These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 24329638)
1. An audit of the use of ondansetron in general medical patients. Cotton PJ; Noaman SQ Med J Aust; 2013 Dec; 199(11):748-50. PubMed ID: 24329638 [No Abstract] [Full Text] [Related]
2. Use of antiemetics in the management of chemotherapy-related nausea and vomiting in current UK practice. Molassiotis A; Brearley SG; Stamataki Z Support Care Cancer; 2011 Jul; 19(7):949-56. PubMed ID: 20574666 [TBL] [Abstract][Full Text] [Related]
3. Adult obesity prescribing in Wiltshire. Harding TK; Cretney N; Gray H; Jones M; Rae M Public Health; 2013 Dec; 127(12):1137-9. PubMed ID: 24275034 [No Abstract] [Full Text] [Related]
4. Standards of oxygen prescribing in Nelson Marlborough District Health Board--showing a problem and making improvements. Sanderson S; Naper J N Z Med J; 2016 Jan; 129(1429):86-9. PubMed ID: 26914306 [No Abstract] [Full Text] [Related]
5. Neither ondansetron nor metoclopramide reduced nausea and vomiting in the emergency department. Pitts SR Ann Intern Med; 2014 Dec; 161(12):JC3. PubMed ID: 25506875 [No Abstract] [Full Text] [Related]
6. Ondansetron: perioperative use of a serotonin receptor antagonist for the prevention and treatment of nausea and vomiting. Early TE; Charbonneau J; McKnight G; Jenkins P J Post Anesth Nurs; 1995 Dec; 10(6):320-3. PubMed ID: 8632370 [TBL] [Abstract][Full Text] [Related]
10. [Region-wide professional practice evaluation with regards to antiemetic prescription into chemotherapy-induced nausea and vomiting]. Tavernier J; Jouannet-Romaszko M; Bertucat H; Marchiset N; Bahadoor M; Chevrier R Bull Cancer; 2016; 103(7-8):622-31. PubMed ID: 27178880 [TBL] [Abstract][Full Text] [Related]
13. Quality of treatment is almost identical. Lischka K Dtsch Arztebl Int; 2011 Jul; 108(28-29):490; author reply 493. PubMed ID: 21814527 [No Abstract] [Full Text] [Related]
14. Consultations not informed by mutual trust. Hector R Dtsch Arztebl Int; 2011 Jul; 108(28-29):490-1; author reply 493. PubMed ID: 21814526 [No Abstract] [Full Text] [Related]
15. Winter 2017 Children's Cancer and Leukaemia Group febrile neutropenia audit. Morgan JE; Phillips B Arch Dis Child; 2018 Dec; 103(12):1187. PubMed ID: 29705724 [No Abstract] [Full Text] [Related]
16. Is ondansetron more effective than granisetron for chemotherapy-induced nausea and vomiting? A review of comparative trials. Vrabel M Clin J Oncol Nurs; 2007 Dec; 11(6):809-13. PubMed ID: 18063539 [TBL] [Abstract][Full Text] [Related]
17. Ondansetron compared with metoclopramide in the treatment of PONV. Harper CM; Barker JP Br J Anaesth; 1998 Mar; 80(3):407-8. PubMed ID: 9623448 [No Abstract] [Full Text] [Related]
18. Audit of proton pump inhibitor (PPI) prescribing: are NICE guidelines being followed? Arasaradnam RP; Woodward T; Parrack L; Bartlett J; Bolton RP Clin Med (Lond); 2003; 3(4):387-8. PubMed ID: 12938761 [No Abstract] [Full Text] [Related]
19. Intraperitoneal ondansetron hydrochloride for intractable nausea and vomiting due to diabetic gastroparesis in a patient on peritoneal dialysis. Amin K; Bastani B Perit Dial Int; 2002; 22(4):539-40. PubMed ID: 12322834 [No Abstract] [Full Text] [Related]
20. Pharmacological treatment of cancer pain and opioid induced nausea and vomiting: online survey and comparison with current guidelines. Gaertner J; Boehlke C; Kreye G; Fusi-Schmidhauser T; Mueller E; Roch C Support Care Cancer; 2024 Jun; 32(7):436. PubMed ID: 38879720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]